MTOR and hepatocellular carcinoma: We also showed that a combination of cisplatin and the PI3K/mTOR inhibitor PKI‐402 induced LMP in HCC cells and then destroyed cisplatin‐induced mitochondrial‐lysosomal crosstalk, which significantly increased the sensitivity of HCC cells to cisplatin (Figure 7).